Recommendation to Use Wearable-Based mHealth in Closed-Loop Management of Acute Cardiovascular Disease Patients During the COVID-19 Pandemic

Because of the rapid and serious nature of acute cardiovascular disease (CVD) especially ST segment elevation myocardial infarction (STEMI), a leading cause of death worldwide, prompt diagnosis and treatment is of crucial importance to reduce both mortality and morbidity. During a pandemic such as coronavirus disease-2019 (COVID-19), it is critical to balance cardiovascular emergencies with infectious risk. In this work, we recommend using wearable device based mobile health (mHealth) as an early screening and real-time monitoring tool to address this balance and facilitate remote monitoring to tackle this unprecedented challenge. This recommendation may help to improve the efficiency and effectiveness of acute CVD patient management while reducing infection risk.

Automated summary

Prompt diagnosis and treatment are crucial in reducing mortality and morbidity in acute cardiovascular diseases, especially ST segment elevation myocardial infarction. During the COVID-19 pandemic, it is essential to balance cardiovascular emergencies with infectious risk. Utilizing wearable devices for early screening and real-time monitoring may improve patient management efficiency and effectiveness while reducing infection risk.